MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Biotechnology_CAR-T (Chimeric Antigen Receptors-T Cell), T Cell Engager (TCE) & T-Cell Research
Nanjing Legend Biotech Corporation (NASDAQ:LEGN)
Organization & Developments: Legend Biotech
Parents
Nanjing Legend Biotech Corporation (NASDAQ:LEGN)
Children
*FDA approval of Carvykti for multiple myeloma with expanding label in major markets.
*Global impact: Puts China-origin cell therapy on the global map, with manufacturing and supply scaled to US and EU demand.
2017: ASCO dark horse Nanjing Legend Biotech shines with promising CAR-T data
2017: Nanjing Legend Biotech_Week In Review: Nearly $2 Billion Late-December Week For China Pharma Deals
2020: Legend Biotech_BCMA rival to bluebird, Bristol Myers files for $100M IPO as the frontrunners stumble in a race to the finish line – Endpoints News
2020: Legend Biotech_FiercePharma
2022: Legend Biotech: Carvykti Approval Makes For A Buy Opportunity_ seekingalpha.com
2022: Legend Biotech: Carvykti Can Exceed J&J's Peak Sales Guidance_ seekingalpha.com
2022: Legend Biotech: Label Expansions Necessary To Realize Carvykti's Potential_ seekingalpha.com
2023: Legend Biotech: Carvykti Is Sailing High, But Watch The Horizon_ seekingalpha.com
2024: Legend Biotech Corporation 2023 Q4 - Results - Earnings Call Presentation
2024: Legend Biotech: AdCom Documents Shed Light On Carvykti's Problems (Downgrade)
2024: Legend Biotech: Solid Traction With Carvykti Rollout
2024: Legend Biotech: The Story Brightens
2024: Legend Biotech's CARVYKTI® Sales Surge 88% YoY to $286M, Expands Global Reach
2024: Legend Biotech's SWOT analysis: stock shows promise amid CAR-T therapy growth
2025: From No Hope to a Potential Cure for a Deadly Blood Cancer
2025: Legend Biotech's Carvykti Is Taking Off, And It's Still Early (Rating Upgrade)_seekingalpha.com
Jumps
Finance & Acquisitions: Legend Biotech
Key People: Legend Biotech